Good post and from the linked extract below shows the benefits of Bisantrene’s cardioprotection can aid in reducing cardio toxicity risk while increasing dox’s efficacy and safety to ensure the cancer is able to be fully treated and not stopped due to the downside risks.
Cardioprotection thread, page-433
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
0.040(3.28%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.27 | $1.19 | $119.8K | 97.24K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1526 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 1986 | 1 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.23 |
Change
0.040 ( 2.94 %) |
||||
| Open | High | Low | Volume | ||
| $1.22 | $1.27 | $1.20 | 20698 | ||
| Last updated 15.58pm 08/05/2024 ? | |||||
| RAC (ASX) Chart |